GlassScriptPhysician profile
Steven D Penner
NPI 1881656882
$829.27
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $75.98 · 2021: $84.40 · 2022: $246 · 2023: $55.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $147.35 | 2019-2023 | Rybelsus, Ozempic |
| Amgen INC. | $111.86 | 2019-2022 | |
| Abbott Laboratories | $93.04 | 2021-2023 | Freestyle Libre 2 |
| Lilly USA, LLC | $61.62 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $54.47 | 2019 | |
| Glaxosmithkline, LLC. | $41.42 | 2022 | |
| Sanofi-Aventis U.S. LLC | $36.01 | 2022 | |
| Novartis Pharmaceuticals Corporation | $35.96 | 2019-2022 | |
| Sanofi Pasteur INC. | $35.73 | 2019 | |
| Mylan Specialty L.P. | $28.91 | 2019 | |
| Amarin Pharma, INC. | $27.04 | 2019-2020 | |
| Nevro Corp. | $24.33 | 2022 | |
| Eisai INC. | $18.48 | 2020 | |
| Astellas Pharma US INC | $17.74 | 2021 | |
| Abbvie INC. | $15.37 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $15.08 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.61 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.18 | 2019 | |
| Alfasigma USA, INC. | $12.57 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Penner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.